Back Mojsov, Svetlana, interviewed by Lara Marks, 10 Jan 2025, unpublished transcript
For Eli Lilly, the equivalent prior time period was 9/27/19 at which point their market cap was $122.4 bn, equaling a $140.1 bn gain to the reference time point of 5/13/22 (Mounjaros launch)
Patients and healthcare systems are eager for cheaper yet effective options
Injections are given subcutaneously abdomen, thigh, or upper arm are best
Large trials such as LEADER, SUSTAIN-6, REWIND, SELECT, and SOUL show fewer heart attacks, strokes, and cardiovascular deaths in selected patients
It is no exaggeration to say that the appearance of the antibody has repainted the conventional idea